Investment Summary

Sipp Industries Invests In Calypso Pharmaceuticals

On May 1, 2024, Sipp Industries invested in life science company Calypso Pharmaceuticals

Investment Highlights
  • This is Sipp Industries’ 1st transaction in the Life Science sector.
  • This is Sipp Industries’ 1st transaction in the United States.
  • This is Sipp Industries’ 1st transaction in Texas.

Investment Summary

Date 2024-05-01
Target Calypso Pharmaceuticals
Sector Life Science
Investor(s) Sipp Industries
Deal Type Stake Purchase

Target

Calypso Pharmaceuticals

Dallas, Texas, United States
Calypso Pharmaceuticals specializes in developing niche products such as beverages, nasal sprays, edibles, topicals, and water-soluble nano-emulsified products tailored for the cannabis and hemp markets. Calypso Pharmaceuticals is based in Dallas, Texas.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Sipp Industries

Costa Mesa, California, United States

Category Company
Founded 1993
Sector Distribution
Revenue 1M USD (2024)
DESCRIPTION

Sipp Industries is a conglomerate company, engages in technology, import and export, and distribution of commercial and consumer products. It primarily offers a line of advanced plasma lighting solutions for indoor horticulture applications. Sipp Industries was founded in 1993 and is based in Costa Mesa, California.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Stake Purchase M&A Deals 1 of 1
State: Texas M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2024 M&A 1 of 1